Furthermore, in a multivariable adjusted model including age, tumor grade, family history, VCA-IgA, EBNA1/IgA, and BMI in NPC patients, circulating adiponectin remained an independent predictor of MFS (HR, 0.245; 95% CI: 0.0.080–0.745; p = 0.013) (Table 2). Here, ADIPOQ is linked to neoplasm.